fbpx
vaccines-america-diplomacy

Moderna Begins Trials for An HIV Vaccine Using mRNA

The project, which also involves the Bill & Melinda Gates Foundation, will follow patients for at least six months.

[Leer en español]

Moderna Pharmaceuticals and the International AIDS Vaccine Initiative (IAVI) announced Thursday that they have begun clinical trials of an HIV vaccine using messenger RNA (mRNA) technology, the same technology used for its Covid-19 vaccine.

In a statement, the company said the first doses of the experimental product have begun to be administered at a Washington hospital as part of a Phase 1 trial involving 56 HIV-negative adults.

The vaccine seeks to stimulate the production of antibodies capable of acting against different variants of circulating HIV with a first dose and a booster dose via mRNA.

Moderna’s CEO, Stephen Hoge, said that mRNA offers a unique opportunity to address a variety of health needs around the world and considered that moving forward with this HIV program is a very important step.

The project, which also involves the Bill & Melinda Gates Foundation, will follow patients for at least six months and their immune responses will be analyzed at the molecular level to assess the responses achieved.

Moderna is working on more than two dozen programs using mRNA technology, including potential vaccines for influenza or the Nipah virus, among others.

Is Biden to Blame For The Dramatic Rise of Inflation?*
This poll gives you free access to our premium politics newsletter. Unsubscribe at any time.
This field is for validation purposes and should be left unchanged.

So far, its vaccine against Covid-19 is the only one approved of all those developed by the company.

Previous Article
Administración Biden le pidió a China que interceda para evitar una guerra en Ucrania

Biden Administration Asked China to Intercede and Avoid War in Ukraine

Next Article

Why Is the Biden Administration Releasing Illegal Migrants with Criminal Records?

Related Posts
Total
0
Share